Cargando…
Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival
Hepatoma‐derived growth factor (HDGF) was previously shown to be associated with increased mortality in a small study of idiopathic and connective tissue disease‐associated pulmonary arterial hypertension (PAH). In this study, we measured serum HDGF levels in a large multicenter cohort (total 2017 a...
Autores principales: | Yang, Jun, Ambade, Anjira S., Nies, Melanie, Griffiths, Megan, Damico, Rachel, Vaidya, Dhananjay, Brandal, Stephanie, Pauciulo, Michael W., Lutz, Katie A., Coleman, Anna W., Nichols, William C., Austin, Eric D., Ivy, Dunbar, Hassoun, Paul M., Everett, Allen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052972/ https://www.ncbi.nlm.nih.gov/pubmed/35506100 http://dx.doi.org/10.1002/pul2.12007 |
Ejemplares similares
-
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2021) -
COL18A1 genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association study
por: Simpson, Catherine E., et al.
Publicado: (2022) -
Insulin‐like growth factor binding Protein‐4: A novel indicator of pulmonary arterial hypertension severity and survival
por: Torres, Guillermo, et al.
Publicado: (2023) -
Pediatric Pulmonary Hypertension: Insulin Like Growth Factor Binding Protein 2 is a novel marker associated with disease severity and survival
por: Griffiths, Megan, et al.
Publicado: (2020) -
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival
por: Yang, Jun, et al.
Publicado: (2020)